Onco Access vs Tech Spert AI
Onco Access vs Tech Spert AI, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Onco Access is on 15/100 and Tech Spert AI on 51/100.
Where each one leads
Onco Access
Leads on none of the measures we hold for both companies.
Tech Spert AI
- our overall score: 51/100 against 15/100
- agent readiness: 40/100 against 26/100
At a glance
| Measure | Onco Access | Tech Spert AI |
|---|---|---|
| What it is | OncoAccess provides a platform for oncology clinical trial matching and patient access. | Primary research platform connecting healthcare and life sciences knowledge seekers with subject matter experts. |
| Category | HealthTech, MedTech, Clinical Trials, Drug Discovery | HealthTech, MedTech, Life Sciences, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2023 | 2018 |
| Headquarters | New York, United States | Ramat Gan, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Onco Access | Tech Spert AI |
|---|---|---|
| Total funding | Not published | $11.3M |
| Latest round | Grant | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Onco Access | Tech Spert AI |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 15/100 | 51/100 |
| Traction | Not published | 35/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 5/100 | 15/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (26/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | Not published | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Onco Access | Tech Spert AI |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Cloudflare | Cloudflare |
| Frameworks | Not detected | React |
| Analytics | Not detected | Google Tag Manager |
Onco Access vs Tech Spert AI: common questions
Which is better, Onco Access or Tech Spert AI?
On our 0-100 score Tech Spert AI rates higher (51/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Onco Access and Tech Spert AI compare on the numbers?
Tech Spert AI leads on our overall score (51/100 against 15/100), agent readiness (40/100 against 26/100).
Read the full Onco Access review and pricing or the Tech Spert AI review and pricing. You can also browse other Onco Access alternatives we track.